SCHEMBL723321

SCHEMBL723321

CCc1ccc2c(c1C1=CC=CC1)Cc1ccccc1-2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.40
PGR P06401 1/20 0.38
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
MAP3K9 P80192 1/20 0.34
MAP3K11 Q16584 1/20 0.34
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
DRD3 P35462 1/20 0.33
SRD5A2 P31213 1/20 0.33
KDM4E B2RXH2 3/20 0.32
HTR2B P41595 2/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
HTR7 P34969 1/20 0.32
MAOA P21397 2/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6673850 0.81 PNMT (0.39) PNMTPGRNPC1RAB9ADRD2
SCHEMBL27424771 0.80 PNMT (0.34) PNMTNPC1RAB9ASRD5A2
SCHEMBL8718651 0.80 PGR (0.39) PNMTPGRNPC1RAB9ASRD5A2
Hydrochloric Acid SCHEMBL27478600 0.79 PNMT (0.33) PNMTNPC1RAB9AMAP3K9MAP3K11
SCHEMBL27387753 0.76 MAP3K9 (0.33) PNMTMAP3K9MAP3K11
SCHEMBL27348144 0.76 PNMT (0.45) PNMTPGRNPC1RAB9AMAP3K9
Hydrochloric Acid SCHEMBL7772278 0.76 PNMT (0.32) PNMT
SCHEMBL6671923 0.76 PNMT (0.37) PNMTPGRNPC1RAB9ADRD2
Hydrochloric Acid SCHEMBL27501681 0.75 MAP3K9 (0.35) MAP3K9MAP3K11
SCHEMBL28286932 0.75 PNMT (0.44) PNMTPGRNPC1RAB9AMAP3K9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2226326-B1 METHOD FOR PRODUCING ORGANIC ALKALI METAL COMPOUND AND METHOD FOR PRODUCING ORGANIC TRANSITION METAL COMPOUND MITSUI CHEMICALS INC (JP) 2016-02-17 EP disclosed
US-8409480-B2 Process for preparing organic alkali metal compound and organic transition metal compound MITSUI CHEMICALS, INC. (JP) 2013-04-02 US disclosed
US-20120049391-A1 PROCESS FOR PREPARING ORGANIC ALKALI METAL COMPOUND AND ORGANIC TRANSITION METAL COMPOUND MITSUI CHEMICALS, INC. 2012-03-01 US disclosed
EP-2226326-A1 METHOD FOR PRODUCING ORGANIC ALKALI METAL COMPOUND AND METHOD FOR PRODUCING ORGANIC TRANSITION METAL COMPOUND Mitsui Chemicals, Inc. (JP) 2010-09-08 EP disclosed
US-6255417-B1 PREPARING OLEFINIC POLYMER IN ALIPHATIC HYDROCARBON SOLVENT USING MODIFIED METALLOCENE CATALYST HAVING AT LEAST ONE ALKYL SUBSTITUENT TO INCREASE SOLUBILITY IN SOLVENT, THEREBY INCREASING ACTIVITY LG CHEMICAL LTD. (KR) 2001-07-03 US disclosed
EP-0863920-B1 PROCESS FOR THE PREPARATION OF OLEFINIC POLYMERS USING METALLOCENE CATALYST LG CHEMICAL LTD (KR) 2001-02-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120049391-A1 PROCESS FOR PREPARING ORGANIC ALKALI METAL COMPOUND AND ORGANIC TRANSITION METAL COMPOUND NHP2, SSRP1, RER1 PNMT 2836/4885PGR 2629/4885NPC1 2382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.